Tempest Therapeutics Inc (NASDAQ: TPST) is -73.41% lower on its value in year-to-date trading and has touched a low of $0.92 and a high of $9.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TPST stock was last observed hovering at around $1.07 in the last trading session, with the day’s gains setting it 0.1%.
Currently trading at $1.17, the stock is -10.16% and -11.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.84 million and changing 9.35% at the moment leaves the stock -58.65% off its SMA200. TPST registered -67.86% loss for a year compared to 6-month loss of -65.07%. The firm has a 50-day simple moving average (SMA 50) of $1.32404 and a 200-day simple moving average (SMA200) of $2.829385.
The stock witnessed a -13.97% gain in the last 1 month and extending the period to 3 months gives it a -44.29%, and is -15.83% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.91% over the week and 10.76% over the month.
Tempest Therapeutics Inc (TPST) has around 17 employees, a market worth around $29.50M and $0.00M in sales. Distance from 52-week low is 27.16% and -87.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-114.99%).
The EPS is expected to grow by 22.35% this year.
Tempest Therapeutics Inc (TPST) Top Institutional Holders
28.0 institutions hold shares in Tempest Therapeutics Inc (TPST), with institutional investors hold 22.49% of the company’s shares. The shares outstanding are 22.05M, and float is at 21.19M with Short Float at 8.79%. Institutions hold 22.43% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.55 million shares valued at $1.21 million. The investor’s holdings represent 2.4747% of the TPST Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 0.43 million shares valued at $0.95 million to account for 1.9426 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 0.18 million shares representing 0.7924% and valued at over $0.39 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.6937 of the shares totaling 0.15 million with a market value of $0.34 million.
Tempest Therapeutics Inc (TPST) Insider Activity
#####
Tempest Therapeutics Inc disclosed in a document filed with the SEC on Aug 08 ’24 that Versant Venture Capital VI, L. (10% Owner) sold a total of 400,000 shares of the company’s common stock. The trade occurred on Aug 08 ’24 and was made at $1.35 per share for $0.54 million. Following the transaction, the insider now directly holds 0.6 million shares of the TPST stock.
Still, SEC filings show that on Aug 12 ’24, Versant Venture Capital VI, L. (10% Owner) disposed off 387,999 shares at an average price of $1.10 for $0.43 million. The insider now directly holds 209,941 shares of Tempest Therapeutics Inc (TPST).
